GLP-1 Medicines Review: South Africa Moves to Expand Access

Original Article by Tamar Kahn | Business Day | 1 December 2025

NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
More Articles

Dis-Chem Insurance Branding Non-Compliant says CMS

Dis-Chem health insurance branding issues raise enforcement risk for Centriq’s MyHealth products and potential disruption for policyholders.

Click Here

National Health Insurance Negotiations: SAMA Seeks NHI Talks

National Health Insurance Negotiations: SAMA meets Motsoaledi after Godongwana urges NHI litigants to seek a settlement.

Click Here

NHI Truce Talks: Godongwana Pushes Settlement On NHI

NHI truce talks could end court battles and shift focus to workable reforms for universal health coverage.

Click Here